PARIS -- Leading experts which met here for the European College of Neuropsychopharmacology (
ENCP) congress held here from 3-7 September 2011, discussed and evaluated the latest achievements and future perspectives in the field of neuropsychopharmacology, including bipolar disorder, schizophrenia, depression, anxiety, drugs and addiction, cognitive impairment and Alzheimer's disease, Attention Deficit Hyperactivity Disorder (ADHD), Obsessive Compulsive Disorder (OCD), and paraphilia, as well as basic neuroscience and psychopharmacology.